Position in VTRS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,716,034
-$4,744,276 QoQ
Shares Held
1,052,647
-33.7% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
5.43%
of 13F equity value
Holder Rank
#91
of 1,020 holders
Holding Since
Dec 2024
7 quarters on record
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bastion Asset Management Inc. holds $23,803,052 across 2 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (70.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
This page
|
1,052,647 | $16,716,034 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
209,180 | $7,087,018 |
All Filings in VTRS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,716,034 | 1,052,647 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $21,460,310 | 1,588,476 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $15,436,655 | 1,239,892 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,243,246 | 630,631 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,934,503 | 552,576 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,038,652 | 463,680 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $14,569,475 | 1,170,239 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||